{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:18:37Z","timestamp":1790518717073,"version":"4.1.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T00:00:00Z","timestamp":1562112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0217749","type":"journal-article","created":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T17:27:06Z","timestamp":1562174826000},"page":"e0217749","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":50,"title":["Varicella zoster immune globulin (VARIZIG) administration up to 10 days after varicella exposure in pregnant women, immunocompromised participants, and infants: Varicella outcomes and safety results from a large, open-label, expanded-access program"],"prefix":"10.1371","volume":"14","author":[{"given":"Myron J.","family":"Levin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Duchon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geeta K.","family":"Swamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne A.","family":"Gershon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,7,3]]},"reference":[{"key":"ref1","unstructured":"Monitoring the impact of varicella vaccination. Centers for Disease Control and Prevention; 2018; May 16. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.cdc.gov\/chickenpox\/surveillance\/monitoring-varicella.html\" xlink:type=\"simple\">https:\/\/www.cdc.gov\/chickenpox\/surveillance\/monitoring-varicella.html<\/ext-link>"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"902","DOI":"10.15585\/mmwr.mm6534a4","article-title":"Epidemiology of Varicella During the 2-Dose Varicella Vaccination Program\u2014United States, 2005\u20132014","volume":"65","author":"AS Lopez","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref3","unstructured":"Singles overview. Centers for Disease Control and Prevention; 2018; Aug 9. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.cdc.gov\/shingles\/about\/overview.html\" xlink:type=\"simple\">https:\/\/www.cdc.gov\/shingles\/about\/overview.html<\/ext-link>"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"859","DOI":"10.7326\/0003-4819-100-6-859","article-title":"Recommendations of the Immunization Practices Advisory Committee, Centers for Disease Control","volume":"100","year":"1984","journal-title":"Ann Intern Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1542\/peds.56.3.388","article-title":"Varicella in children with cancer: Seventy-seven cases","volume":"56","author":"S Feldman","year":"1975","journal-title":"Pediatrics"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00277-013-1951-6","article-title":"Incidence, risk factors, and implemented prophylaxis of varicella zoster virus infection, including complicated varicella zoster virus and herpes simplex virus infections, in lenalidomide-treated multiple myeloma patients","volume":"93","author":"C Konig","year":"2014","journal-title":"Ann Hematol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7326\/0003-4819-108-2-221","article-title":"NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment, and prevention","volume":"108","author":"SE Straus","year":"1988","journal-title":"Ann Intern Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/infdis\/147.4.737","article-title":"Evaluation of varicella-zoster immune globulin: protection of immunosuppressed children after household exposure to varicella","volume":"147","author":"JA Zaia","year":"1983","journal-title":"J Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/infdis\/129.2.215","article-title":"Congenital varicella in term infants: risk reconsidered","volume":"129","author":"JD Meyers","year":"1974","journal-title":"J Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1542\/peds.68.1.14","article-title":"Age-specific risks of varicella complications","volume":"68","author":"SR Preblud","year":"1981","journal-title":"Pediatrics"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1471-0528.2011.02983.x","article-title":"Varicella-zoster virus (chickenpox) infection in pregnancy","volume":"118","author":"RF Lamont","year":"2011","journal-title":"BJOG"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1086\/338832","article-title":"Risk factors and outcome of varicella-zoster virus pneumonia in pregnant women","volume":"185","author":"JH Harger","year":"2002","journal-title":"J Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/jog.12479","article-title":"Maternal outcomes in pregnancies affected by varicella zoster virus infections: population-based study on 7.7 million pregnancy admissions","volume":"41","author":"HJ Zhang","year":"2015","journal-title":"J Obstet Gynaecol Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1503\/cmaj.100615","article-title":"Congenital varicella syndrome: the evidence for secondary prevention with varicella-zoster immune globulin","volume":"183","author":"A Cohen","year":"2011","journal-title":"CMAJ"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/S0140-6736(94)92943-2","article-title":"Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases","volume":"343","author":"G Enders","year":"1994","journal-title":"Lancet"},{"key":"ref16","first-page":"260","article-title":"Frequency of congenital varicella syndrome in a prospective cohort of 347 pregnant women","volume":"100","author":"JH Harger","year":"2002","journal-title":"Obstet Gynecol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1155\/1996\/910592","article-title":"Varicella zoster immune globulin use in neonates and infants","volume":"7","year":"1996","journal-title":"Can J Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0140-6736(89)90547-3","article-title":"Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus","volume":"2","author":"E Miller","year":"1989","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJM196208232670801","article-title":"Modification of chicken pox in family contacts by administration of gamma globulin","volume":"267","author":"AH Ross","year":"1962","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1542\/peds.50.5.718","article-title":"Prevention of varicella in high risk children: a collaborative study","volume":"50","author":"PA Brunell","year":"1972","journal-title":"Pediatrics"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJM196905292802201","article-title":"Prevention of varicella by zoster immune globulin","volume":"280","author":"PA Brunell","year":"1969","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM197401312900503","article-title":"Zoster immune globulin. A further assessment","volume":"290","author":"AA Gershon","year":"1974","journal-title":"N Engl J Med"},{"key":"ref23","first-page":"1","article-title":"Varicella-zoster immunoglobulin treatment in pregnant women in Denmark from 2005 to 2015: descriptive epidemiology and follow-up","volume":"2016","author":"C Jespersen","journal-title":"Epidemiol Infect"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/QCO.0b013e328345d666","article-title":"Preventing varicella in children with malignancies: what is the evidence?","volume":"24","author":"JP Fisher","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1651-2227.1978.tb16280.x","article-title":"Efficacy of zoster immunoglobulin in prophylaxis of varicella in high-risk patients","volume":"67","author":"R Winsnes","year":"1978","journal-title":"Acta Paediatr Scand"},{"key":"ref26","first-page":"209","article-title":"A new product (VariZIG) for postexposure prophylaxis of varicella available under an investigational new drug application expanded access protocol","volume":"55","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref27","unstructured":"VARIZIG\u00ae (Varicella zoster immune globulin [human]). [prescribing information]. Saol Therapeutics. Roswell, GA 2018; Aug 21. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/varizig.com\/VARIZIG_LQ_USPI.pdf\" xlink:type=\"simple\">https:\/\/varizig.com\/VARIZIG_LQ_USPI.pdf<\/ext-link>"},{"key":"ref28","first-page":"574","article-title":"Updated recommendations for use of VariZIG\u2014United States, 2013","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/00912700222011283","article-title":"Serum concentrations, efficacy, and safety of a new, intravenously administered varicella zoster immune globulin in pregnant women","volume":"42","author":"G Koren","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1056\/NEJMc1209037","article-title":"Vaccination policies and rates of exemption from immunization, 2005\u20132011","volume":"367","author":"SB Omer","year":"2012","journal-title":"N Engl J Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1542\/peds.80.4.465","article-title":"Varicella in children with cancer: impact of antiviral therapy and prophylaxis","volume":"80","author":"S Feldman","year":"1987","journal-title":"Pediatrics"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1542\/peds.28.3.436","article-title":"Mortality from varicella in children receiving adrenocorticosteroids and adrenocorticotropin","volume":"28","author":"KC Finkel","year":"1961","journal-title":"Pediatrics"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/1097-0142(197504)35:4<1027::AID-CNCR2820350402>3.0.CO;2-9","article-title":"Prophylaxis of varicella in children with neoplastic disease: comparative results with zoster immune plasma and gamma globulin","volume":"35","author":"CF Geiser","year":"1975","journal-title":"Cancer"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/archpedi.1983.02140350057014","article-title":"Varicella in immunocompromised children. Incidence of abdominal pain and organ involvement","volume":"137","author":"ER Morgan","year":"1983","journal-title":"Am J Dis Child"},{"key":"ref35","article-title":"Epidemiology, management and outcome of varicella in pregnancy: a 20-year experience at the Tuscany Reference Centre for Infectious Diseases in Pregnancy","author":"M Trotta","year":"2018","journal-title":"Infection"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1586\/14760584.2013.844651","article-title":"The role of VariZIG in pregnancy","volume":"12","author":"P Bapat","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"ref37","first-page":"559","article-title":"Towards evidence based medicine for paediatricians. How effective is varicella-zoster immunoglobulin (VZIG) in preventing chickenpox in neonates following perinatal exposure?","volume":"94","author":"M Tebruegge","year":"2009","journal-title":"Arch Dis Child"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0022-3476(79)80407-2","article-title":"Congenital and neonatal varicella","volume":"94","author":"LK DeNicola","year":"1979","journal-title":"J Pediatr"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/adc.69.6.639","article-title":"Effect of oral acyclovir against primary and secondary viraemia in incubation period of varicella","volume":"69","author":"S Suga","year":"1993","journal-title":"Arch Dis Child"},{"key":"ref40","article-title":"PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer","author":"J Bate","year":"2018","journal-title":"Arch Dis Child"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/tropej\/fmv008","article-title":"Successful prevention of varicella outbreak in an overcrowded paediatric oncology ward using oral acyclovir prophylaxis","volume":"61","author":"A Kumar","year":"2015","journal-title":"J Trop Pediatr"},{"key":"ref42","unstructured":"Expanded access to investigational drugs for treatment use. Food and Drug Administration; 2018; Aug 21. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.fda.gov\/downloads\/drugs\/guidances\/ucm351261.pdf\" xlink:type=\"simple\">https:\/\/www.fda.gov\/downloads\/drugs\/guidances\/ucm351261.pdf<\/ext-link>"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0217749","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T21:49:24Z","timestamp":1663883364000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0217749"}},"subtitle":[],"editor":[{"given":"Ray","family":"Borrow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,7,3]]},"references-count":42,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,7,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0217749","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,3]]}}}